Your browser doesn't support javascript.
loading
A Novel Allosteric Insulin Receptor-Activating Antibody Reduces Hyperglycemia without Hypoglycemia in Diabetic Cynomolgus Monkeys.
Bezwada, Padma; Zhao, Jingsong; Der, Ken; Shimizu, Bob; Cao, Liching; Ahene, Ago; Rubin, Paul; Johnson, Kirk.
Afiliação
  • Bezwada P; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California bezwada@xoma.com.
  • Zhao J; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
  • Der K; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
  • Shimizu B; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
  • Cao L; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
  • Ahene A; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
  • Rubin P; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
  • Johnson K; Preclinical Development, XOMA Corporation, 2910 Seventh Street, Berkeley California.
J Pharmacol Exp Ther ; 356(2): 466-73, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26578267
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Insulina / Antígenos CD / Diabetes Mellitus Tipo 2 / Hiperglicemia / Hipoglicemia / Hipoglicemiantes Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Insulina / Antígenos CD / Diabetes Mellitus Tipo 2 / Hiperglicemia / Hipoglicemia / Hipoglicemiantes Idioma: En Ano de publicação: 2016 Tipo de documento: Article